In today’s episode, Cedarville alumnus, Dr. Ryley Uber, will be discussing the practice of pharmacogenomics, which is how an individual’s genetic code can affect the way different medications interact and are processed within the body. The implications of research in this field are enormous. From pharmacovigilance to personalized medication dosing, everyone involved in the medication process stands to benefit from pharmacogenomic data. Dr. Uber’s interest in pharmacogenomics began during his time at Cedarville, which led to an internship studying pharmacogenomics with the FDA. He then serves as the first Clinical Pharmacogenomics Fellow with the University of Pittsburgh School of Pharmacy and Medical Center. He now serves as Pharmacogenomics Program Director for Geisinger Health. Listen in to hear Dr. Uber discuss how pharmacogenomics is being implemented in the medical world and how it may affect your medication use for the better.